Study: Rapid treatment boosts survival odds for stroke victims

06/18/2013 | HealthDay News · EverydayHealth.com

A study in the Journal of the American Medical Association showed that the earlier a stroke patient receives clot-dissolving drugs, the better the outcome. Researchers looked at data from more than 58,000 ischemic stroke patients. Patients treated with tissue plasminogen activators within 90 minutes of symptom onset had a 26% lower risk of death and 28% reduced risk of intracranial hemorrhage than those treated within 181 to 270 minutes, for example.

View Full Article in:

HealthDay News · EverydayHealth.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD